Dave & Buster's Entertainment reported a quarterly loss alongside declining sales, triggering a 12% drop in its share price to $7.43. The pressure was similarly acute for Kestra Medical Technologies, where shares fell 10% to $21.76 as the company posted a loss that exceeded analyst expectations.

Contineum Therapeutics faced its own headwinds after a clinical trial for a new depression treatment failed to reach its primary endpoint. The announcement pushed the stock down 4% to $14.30. Conversely, Boxlight provided a moment of stability for traders, rising 6% to $5.75 after the company successfully restored its compliance with Nasdaq listing requirements.